bf/NASDAQ:RDHL_icon.jpeg

NASDAQ:RDHL

RedHill Biopharma Ltd.

  • Stock

USD

Last Close

9.89

25/09 13:59

Market Cap

11.60M

Beta: 2.16

Volume Today

10.09K

Avg: 100.31K

PE Ratio

−0.19

PFCF: −0.39

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
12K
-
7.01M
58,350%
3K
99.96%
101K
3,266.67%
4.01M
3,867.33%
8.36M
108.63%
6.29M
24.75%
64.36M
923.03%
85.76M
33.25%
61.80M
27.94%
6.51M
89.46%
cost of revenue
1.05M
-
22.00M
1,995.43%
30.54M
38.82%
2.13M
93.04%
2.84M
33.44%
2.26M
20.37%
36.89M
1,533.11%
49.41M
33.92%
33.34M
32.52%
3.45M
89.65%
gross profit
12K
-
5.96M
49,600%
-22.00M
468.86%
-30.44M
38.38%
1.88M
106.18%
5.52M
193.62%
4.03M
27.00%
27.47M
581.23%
36.35M
32.34%
28.46M
21.70%
3.06M
89.24%
selling and marketing expenses
12.01M
-
12.49M
3.93%
18.33M
46.83%
49.28M
168.83%
11.38M
76.90%
9.06M
20.44%
general and administrative expenses
2.68M
-
4.01M
49.44%
4.13M
3.07%
5.40M
30.70%
8.03M
48.53%
7.51M
6.47%
11.48M
52.96%
25.38M
121.02%
76.60M
201.88%
54.97M
28.24%
selling general and administrative expenses
2.68M
-
4.01M
49.44%
4.13M
3.07%
5.40M
30.70%
20.04M
270.89%
19.99M
0.23%
29.81M
49.13%
74.66M
150.42%
87.99M
17.85%
64.03M
27.23%
30.90M
51.75%
research and development expenses
8.10M
-
12.70M
56.79%
17.77M
39.93%
25.24M
42.03%
32.97M
30.62%
24.86M
24.59%
17.42M
29.94%
16.49M
5.33%
29.50M
78.87%
7.28M
75.32%
3.52M
51.66%
other expenses
-100K
-
100K
200%
845K
-
cost and expenses
10.78M
-
17.66M
63.77%
22.00M
24.60%
30.64M
39.26%
55.98M
82.68%
47.69M
14.81%
49.49M
3.78%
128.04M
158.71%
166.89M
30.34%
104.64M
37.30%
37.86M
63.82%
operating expenses
10.78M
-
16.61M
54.03%
22.00M
32.47%
30.64M
39.26%
53.85M
75.74%
44.85M
16.71%
47.23M
5.30%
91.15M
92.98%
117.49M
28.89%
71.31M
39.31%
34.41M
51.74%
interest expense
14K
-
383K
2,635.71%
212K
44.65%
375K
76.89%
77K
79.47%
167K
116.88%
438K
162.28%
12.76M
2,813.01%
16.57M
29.85%
41.33M
149.49%
426.90K
98.97%
ebitda
-10.59M
-
-10.30M
2.73%
-20.84M
102.33%
-28.95M
38.91%
-45.39M
56.77%
-38.56M
15.03%
-40.65M
5.42%
-54.67M
34.48%
-63M
15.24%
-34.61M
45.07%
-29.37M
15.14%
operating income
-10.77M
-
-10.65M
1.16%
-22.00M
106.65%
-30.54M
38.82%
-51.97M
70.16%
-39.33M
24.32%
-43.20M
9.84%
-63.68M
47.41%
-81.14M
27.40%
-42.84M
47.19%
-31.35M
26.83%
depreciation and amortization
24K
-
27K
12.50%
36K
33.33%
44K
22.22%
81K
84.09%
90K
11.11%
2.55M
2,731.11%
9.02M
253.81%
18.14M
101.16%
8.24M
54.57%
1.98M
75.91%
total other income expenses net
128K
-
-161K
225.78%
688K
527.33%
898K
30.52%
6.21M
591.31%
274K
95.59%
897K
227.37%
-12.49M
1,492.31%
-16.61M
32.99%
-28.82M
73.55%
55.21M
291.52%
income before tax
-10.63M
-
-10.71M
0.78%
-21.09M
96.90%
-29.37M
39.26%
-45.54M
55.07%
-38.82M
14.76%
-42.30M
8.97%
-76.17M
80.06%
-97.74M
28.32%
-71.67M
26.68%
23.85M
133.28%
income tax expense
142K
-
222K
56.34%
900K
305.41%
1.27M
41.44%
6.29M
393.72%
727K
88.43%
1.33M
82.94%
12.84M
865.71%
16.57M
28.99%
-12.42M
174.99%
-2
100.00%
net income
-10.63M
-
-10.71M
0.78%
-21.09M
96.90%
-29.37M
39.26%
-45.54M
55.07%
-38.82M
14.76%
-43.63M
12.40%
-89.02M
104.01%
-114.31M
28.41%
-59.24M
48.17%
23.85M
140.26%
weighted average shs out
155.95K
-
216.53K
38.84%
277.04K
27.95%
309.30K
11.65%
437.92K
41.59%
570.88K
30.36%
742.30K
30.03%
910.69K
22.68%
1.16M
27.73%
1.55M
33.10%
6.48M
318.41%
weighted average shs out dil
155.95K
-
218.06K
39.83%
279.29K
28.08%
319.24K
14.30%
437.92K
37.18%
570.88K
30.36%
742.30K
30.03%
910.69K
22.68%
1.16M
27.73%
1.55M
33.10%
6.48M
318.41%
eps
-68.15
-
-49.47
27.41%
-76.13
53.89%
-92
20.85%
-104
13.04%
-68
34.62%
-58.78
13.56%
-97.75
66.30%
-98.27
0.53%
-38.27
61.06%
3.68
109.62%
epsdiluted
-68.15
-
-49.12
27.92%
-75.51
53.73%
-92
21.84%
-104
13.04%
-68
34.62%
-58.78
13.56%
-97.75
66.30%
-98.27
0.53%
-38.27
61.06%
3.68
109.62%

All numbers in USD (except ratios and percentages)